
To curb the epidemic of obesity in the United States, revised Medicare policy allows support for zzso obesity zzso This review summarizes the evidence from rigorous zzso trials (9 lifestyle trials, 5 drug trials, and 2 surgical zzso on the efficacy and zzso benefit profile of lifestyle, drug, and surgical interventions aimed at promoting sustained zzso 2 zzso reductions in zzso Both lifestyle and drug interventions consistently produced an approximate zzso zzso weight loss that was sustained for 2 years and was associated with improvements in diabetes, blood pressure, and/or cardiovascular risk zzso zzso interventions have a less solid empirical base but offer promise for the promotion of significant and sustained weight reduction zzso in the zzso obese but with possible significant short-term side zzso In zzso there is strong and consistent support from rigorous zzso trials that lifestyle or drug interventions result in modest weight loss with minimal risks but disproportionate clinical zzso zzso of lifestyle, drug, and, where appropriate, surgical interventions may be the most zzso approach to achieving sustained weight loss for the zzso diversity of zzso 

